Comparative Pharmacokinetic Analysis of Albendazole Loaded in Solid Lipid Nanoparticles and Microemulsion in Hepatic and Pulmonary Tissues of Experimental Hydatidosis Murine Models
Jundishapur Journal of Natural Pharmaceutical Products · 31.05.2026 · 21 (2)
DOI: 10.5812/jjnpp-170836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jundishapur Journal of Natural Pharmaceutical Products, online erschienen am 31.05.2026. Verfasst von Mahmoud Rahdar und 4 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pharmacological intervention plays a critical role in managing cystic echinococcosis, both preoperatively and postoperatively, to reduce the risk of recurrence and treat inoperable cases. Therefore, enhancing therapeutic efficacy against hydatid cysts through novel albendazole (ABZ) formulations is essential.
Objectives
This study evaluated the tissue-specific drug absorption profiles of ABZ-loaded solid lipid nanoparticles (ABZ-SLNs) and microemulsions (ABZ-MEs) in a BALB/c mouse model of experimental hydatidosis, with the aim of improving tissue drug uptake through nanoparticle-based delivery systems.
Methods
Twenty-five male BALB/c mice were intraperitoneally inoculated with viable Echinococcus granulosus protoscolices isolated from sheep hepatic hydatid cysts. After a 6-month infection establishment period, the animals were stratified into 5 randomized groups (n = 5/group). The study groups received daily oral gavage with albendazole suspension, ABZ-ME, or ABZ-SLN at 20 mg/kg for 30 consecutive days. Subsequently, hepatic and pulmonary tissues were harvested, and the amount of drug extracted from the tissues was measured using high-performance liquid chromatography (HPLC).
Results
Both ABZ-SLN and ABZ-ME had particle sizes < 150 nm, drug loading > 60%, and sustained-release profiles. Tissue ABZ levels were significantly higher with ABZ-SLN and ABZ-ME than with the aqueous suspension (P < 0.05), and pulmonary concentrations exceeded hepatic levels for all formulations.
Conclusions
ABZ-SLN and ABZ-ME significantly enhanced ABZ distribution and tissue uptake, which were attributed to their lipid nature and nanoscale particle size. Their sustained-release profiles suggest that these formulations act as drug depots and enhance systemic therapeutic delivery.
Zitieren
APA
Rahdar, M., Rafiei, A., Safdarian, M., Makhmalzadeh, B. S., & Jahromi, K. F. (2026). Comparative Pharmacokinetic Analysis of Albendazole Loaded in Solid Lipid Nanoparticles and Microemulsion in Hepatic and Pulmonary Tissues of Experimental Hydatidosis Murine Models. Jundishapur Journal of Natural Pharmaceutical Products, 21(2). https://doi.org/10.5812/jjnpp-170836
Vancouver
Rahdar M, Rafiei A, Safdarian M, Makhmalzadeh BS, Jahromi KF. Comparative Pharmacokinetic Analysis of Albendazole Loaded in Solid Lipid Nanoparticles and Microemulsion in Hepatic and Pulmonary Tissues of Experimental Hydatidosis Murine Models. Jundishapur Journal of Natural Pharmaceutical Products. 2026;21(2). doi:10.5812/jjnpp-170836
BibTeX
@article{Rahdar2026,
author = {Rahdar, Mahmoud and Rafiei, Abdollah and Safdarian, Mehdi and Makhmalzadeh, Behzad Sharif and Jahromi, Kereshmeh Fakharzadeh},
title = {Comparative Pharmacokinetic Analysis of Albendazole Loaded in Solid Lipid Nanoparticles and Microemulsion in Hepatic and Pulmonary Tissues of Experimental Hydatidosis Murine Models},
journal = {Jundishapur Journal of Natural Pharmaceutical Products},
year = {2026},
volume = {21},
number = {2},
doi = {10.5812/jjnpp-170836}
}
EUVIMED